CC Diagnostics Completes Methica CC Clinical Validation Study with Groundbreaking Results
CC Diagnostics has successfully completed a large clinical validation study using samples from the Dutch National Screening Program. The results? **97% sensitivity for cancer detection**, outperforming the pap smear by **21%**—all without compromising specificity. This study, conducted across multiple centers, reflects real-world performance and eliminates bias, marking a significant leap forward in cervical cancer diagnostics.